Zur Startseite gehen
0,00 €*
Cover: 9783030860783 | Prevention and Treatment of Atherosclerosis | Binder (u. a.) | Buch
Dekorationsartikel gehören nicht zum Leistungsumfang.
Prevention and Treatment of Atherosclerosis
Improving State-of-the-Art Management and Search for Novel Targets
Taschenbuch von Christoph J. Binder (u. a.)
Sprache: Englisch

42,79 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Aktuell nicht verfügbar

Kategorien:
Beschreibung
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
Über den Autor
Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. ¿Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access
Zusammenfassung

Summarizes the latest studies on the management of cardiovascular risk factors

Reviews exhaustively the key recent research into the pathogenesis of atherosclerotic cardiovascular diseases

Outlines various strategies of identifying and validating novel targets for prevention and treatment of atherosclerosis

This book is open access, which means that you have free and unlimited access

Inhaltsverzeichnis
Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics.
Details
Erscheinungsjahr: 2022
Fachbereich: Andere Fachgebiete
Genre: Medizin
Rubrik: Wissenschaften
Medium: Taschenbuch
Reihe: Handbook of Experimental Pharmacology
Inhalt: x
538 S.
3 s/w Illustr.
37 farbige Illustr.
538 p. 40 illus.
37 illus. in color.
ISBN-13: 9783030860783
ISBN-10: 3030860787
Sprache: Englisch
Ausstattung / Beilage: Paperback
Einband: Kartoniert / Broschiert
Redaktion: Binder, Christoph J.
Eckardstein, Arnold von
Herausgeber: Arnold von Eckardstein/Christoph J Binder
Auflage: 1st ed. 2022
Hersteller: Springer International Publishing
Handbook of Experimental Pharmacology
Maße: 235 x 155 x 28 mm
Von/Mit: Christoph J. Binder (u. a.)
Erscheinungsdatum: 01.02.2022
Gewicht: 0,92 kg
Artikel-ID: 120407091
Über den Autor
Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. ¿Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access
Zusammenfassung

Summarizes the latest studies on the management of cardiovascular risk factors

Reviews exhaustively the key recent research into the pathogenesis of atherosclerotic cardiovascular diseases

Outlines various strategies of identifying and validating novel targets for prevention and treatment of atherosclerosis

This book is open access, which means that you have free and unlimited access

Inhaltsverzeichnis
Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics.
Details
Erscheinungsjahr: 2022
Fachbereich: Andere Fachgebiete
Genre: Medizin
Rubrik: Wissenschaften
Medium: Taschenbuch
Reihe: Handbook of Experimental Pharmacology
Inhalt: x
538 S.
3 s/w Illustr.
37 farbige Illustr.
538 p. 40 illus.
37 illus. in color.
ISBN-13: 9783030860783
ISBN-10: 3030860787
Sprache: Englisch
Ausstattung / Beilage: Paperback
Einband: Kartoniert / Broschiert
Redaktion: Binder, Christoph J.
Eckardstein, Arnold von
Herausgeber: Arnold von Eckardstein/Christoph J Binder
Auflage: 1st ed. 2022
Hersteller: Springer International Publishing
Handbook of Experimental Pharmacology
Maße: 235 x 155 x 28 mm
Von/Mit: Christoph J. Binder (u. a.)
Erscheinungsdatum: 01.02.2022
Gewicht: 0,92 kg
Artikel-ID: 120407091
Warnhinweis

Ähnliche Produkte

Diese Website verwendet Cookies, um eine bestmögliche Erfahrung bieten zu können. Mehr Informationen ...